Recently, we were thrilled to welcome Dr Alison Green to the Leadership Team as our Head of Laboratory Sciences! Read more about what she brings to Scottish Brain Sciences…
Scottish Brain Sciences
News and updates about us
Professor Craig Ritchie has told an international Alzheimer’s conference that phase 3 clinical trial results for donanemab, the antibody drug designed to target and clear the amyloid plaques considered key to progression of Alzheimer’s disease, reveal the drug’s “profound” clinical effect.
Professor Craig Ritchie, CEO of Scottish Brain Sciences co-hosts the second international brain health summit in St Andrew’s, bringing together experts across the NHS, academia, and industry for a two-day conference.
Professor Ritchie spoke with The Times about the drive to advance research at a faster pace than manageable within the NHS.